Tristel plc welcomes the publication of a white paper ? Simplifying High-Level Disinfection for Urological Procedures: A Case Study? at the American Urological Association (?AUA?) 2024 conference, the gathering of urologists in the world.

In June 2023 the Food and Drug Administration (?FDA?) created a new category of Class II medical device disinfectants titled ?foam or gel chemical sterilant/high-level disinfectant? under which De Novo clearance for Tristeltm ULT was granted. As referenced within Dr. Allaway's study, Tristeltm ULT is recognised as a high level disinfectant (?HLD?) and is effective against pathogens ranging from Human papillomavirus (?HPV?) type 16 and type 18 to Mycobacterium terrae.

Tristeltm ULT helps to address numerous bottlenecks that can impact workflow in a busy urology practice. One of the most time-consuming tasks is reprocessing medical devices between procedures. Chemical soaking and misting methods of HLD can damage probes and require complex workflows limiting the number of procedures clinicians can perform during a typical patient list.